Holen Sie sich die Stockscreener-App
2.72
4.23%
-0.12
Handel nachbörslich:
2.73
0.010
+0.37%
Schlusskurs vom Vortag:
$2.84
Offen:
$2.76
24-Stunden-Volumen:
269.80K
Relative Volume:
0.40
Marktkapitalisierung:
$273.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-60.14M
KGV:
-3.8337
EPS:
-0.7095
Netto-Cashflow:
$-68.17M
1W Leistung:
-8.11%
1M Leistung:
-8.11%
6M Leistung:
+19.30%
1J Leistung:
+8.80%
1-Tages-Spanne:
$2.65
$2.85
1-Wochen-Bereich:
$2.65
$2.99
52-Wochen-Spanne:
$1.4299
$4.00
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.72 | 285.70M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-31 | Eingeleitet | BTIG Research | Buy |
| 2019-02-01 | Herabstufung | UBS | Buy → Neutral |
| 2019-01-04 | Eingeleitet | UBS | Buy |
| 2018-04-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | Eingeleitet | Credit Suisse | Outperform |
| 2016-10-18 | Eingeleitet | Jefferies | Buy |
| 2016-10-18 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Ac Immune Sa Aktie (ACIU) Neueste Nachrichten
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026 - GlobeNewswire
AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Will AC Immune SA stock hit new highs in YEAR2025 Historical Comparison & Risk Controlled Swing Alerts - baoquankhu1.vn
AC Immune (ACIU) Begins Phase 1 Trial for New Inflammation Treat - GuruFocus
AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor - Investing.com Nigeria
AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764 - TipRanks
AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor By Investing.com - Investing.com South Africa
AC Immune (NASDAQ: ACIU) begins Phase 1 test of NLRP3 inhibitor ACI-19764 - Stock Titan
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor - The Manila Times
First tests for AC Immune pill targeting brain inflammation in Alzheimer’s - Stock Titan
Can AC Immune SA deliver consistent EPS growthMarket Volume Report & Community Verified Trade Signals - mfd.ru
ACIU Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Retail Trends: What analysts say about Alphabet Inc stock2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
Aug EndMonth: Can AC Immune SA deliver consistent EPS growthTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
J&J Pauses Enrollment In Trial Of AC Immune-Partnered Anti-Tau Immunotherapy - Citeline News & Insights
AC Immune Says Recruitment Temporarily Paused in Ongoing Study for Alzheimer's Disease Treatment - marketscreener.com
Is AC Immune SA stock a buy before product launchesMarket Growth Review & Advanced Swing Trade Entry Alerts - mfd.ru
AC Immune (ACIU) Faces Enrollment Pause in Alzheimer's Trial wit - GuruFocus
AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027 - TipRanks
AC Immune SA announces voluntary suspension of recruitment for its Phase II clinical trial (code-named Retain) for Alzheimer's disease treatment - Bitget
AC Immune (NASDAQ: ACIU) details Alzheimer’s trial pause and 2027 cash runway - Stock Titan
Sagimet Biosciences (NASDAQ:SGMT) vs. AC Immune (NASDAQ:ACIU) Financial Survey - Defense World
Should I buy AC Immune SA stock nowWeekly Loss Report & Verified Trade Idea Suggestions - mfd.ru
What is AC Immune SA s debt to equity ratioEarnings Trend Report & Risk Controlled Swing Alerts - mfd.ru
What is AC Immune SA’s book value per shareWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Aug Movers: Can AC Immune SA weather a recessionJuly 2025 Institutional & Weekly Top Gainers Trade List - baoquankhu1.vn
Is AC Immune SA undervalued by DCF analysisJuly 2025 Recap & AI Driven Stock Price Forecasts - mfd.ru
What is AC Immune SA s revenue forecastJuly 2025 Decliners & Target Return Focused Stock Picks - mfd.ru
Bank Watch: Does AC Immune SA outperform in volatile marketsMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Earnings Beat: Should I trade or invest in CVLGJuly 2025 Market Mood & Low Volatility Stock Suggestions - baoquankhu1.vn
Aug Analyst Calls: Can AC Immune SA weather a recession2025 Market Sentiment & Target Return Focused Stock Picks - baoquankhu1.vn
AC Immune (NASDAQ:ACIU) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Can AC Immune SA weather a recession2025 Valuation Update & Weekly Watchlist for Consistent Profits - mfd.ru
Does AC Immune SA outperform in volatile markets2025 Valuation Update & Weekly High Conviction Ideas - mfd.ru
Will AC Immune SA outperform its industry peersQuarterly Trade Review & Reliable Breakout Stock Forecasts - mfd.ru
Performance Recap: Is Stagwell Inc stock forming a cup and handleGDP Growth & Low Risk High Win Rate Picks - baoquankhu1.vn
Dip Buying: Should I buy AC Immune SA stock nowJuly 2025 Opening Moves & Fast Gain Swing Alerts - baoquankhu1.vn
Will AC Immune SA outperform the market in YEAR2025 Key Highlights & High Win Rate Trade Alerts - Mfd.ru
AC Immune (NASDAQ:ACIU) Stock Price Down 5.4%Time to Sell? - MarketBeat
Profit Recap: Will AC Immune SA outperform its industry peersIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn
Aug Outlook: Will AC Immune SA outperform its industry peersStock Surge & Real-Time Volume Analysis - baoquankhu1.vn
Fed Meeting: Will AC Immune SA outperform its industry peers2025 Market Sentiment & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Risk Off: Why AC Immune SA stock attracts global investors2025 Bull vs Bear & Verified Chart Pattern Trade Signals - Bộ Nội Vụ
Top Penny Stocks To Watch In January 2026 - Yahoo Finance
Trading Recap: Can AC Immune SA stock deliver surprise earnings beatEarnings Overview Report & AI Based Buy/Sell Signal Reports - Bộ Nội Vụ
What insider purchases suggest about AC Immune SA (IMR) stockJuly 2025 Breakouts & Growth Focused Stock Reports - Улправда
What valuation ratios show for AC Immune SA (IMR) stockJuly 2025 Final Week & Weekly High Potential Alerts - Улправда
How AC Immune SA stock benefits from tech adoption2025 Price Targets & Long Hold Capital Preservation Plans - Улправда
How AC Immune SA stock performs after earningsNew Guidance & Expert-Curated Trade Recommendations - ulpravda.ru
Can AC Immune SA stock beat market expectations this quarterMarket Growth Summary & Fast Entry Momentum Trade Alerts - Улправда
Will AC Immune SA stock split again soon2025 EndofYear Setup & Short-Term Trading Alerts - ulpravda.ru
Finanzdaten der Ac Immune Sa-Aktie (ACIU)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):